Atlas Trials

Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction

Clinical trial NCT02442492 · TERMINATED

Trial details

NCT number
NCT02442492
Sponsor
University of British Columbia
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Intrauterine Growth Restriction (IUGR)Fetal Growth Restriction (FGR)
Start date
2017-01-01
Primary completion
2018-07-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.